Cardiol Therapeutics Income Statement (2020-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Shares Outstanding (Entity) (Quarter)	40.06M	43.17M	43.22M	61.93M	61.93M	62.34M	62.51M	64.09M	64.11M	64.49M	64.46M	67.26M	68.75M	69.84M	71.57M	82.61M	82.65M	84.73M	86.99M	108.99M
Operating items
Amortization - Intangibles (Quarter)	0.02M
Depreciation & Amortization - Total (Quarter)	0.03M
Research & Development (Quarter)	1.69M	2.06M	2.80M	3.04M	3.46M	3.90M	4.14M	3.05M	2.59M	1.92M	2.97M	2.47M	1.98M	2.75M	3.03M	2.62M	1.97M	3.48M	1.97M	3.61M
Wages, Salaries and Other (Quarter)	0.92M
Selling, General & Administrative (Quarter)	3.60M	6.01M	7.59M	4.69M	3.78M	6.23M	2.56M	2.71M	2.11M	3.79M	2.93M	3.77M	3.68M	7.62M	4.12M	3.26M	3.57M	3.92M	3.79M	3.47M
Restructuring Costs (Quarter)	1.16M
Operating Expenses (Quarter)	6.48M	8.07M	10.39M	7.73M	7.24M	10.14M	6.70M	5.76M	4.70M	5.71M	5.90M	6.24M	5.66M	10.37M	7.15M	5.87M	5.54M	7.40M	5.76M	7.08M
Operating Income (Quarter)	-5.23M	-8.07M	-10.39M	-7.73M	-7.24M	-10.14M	-6.70M					-6.24M				-5.87M				-7.08M
EBIT (Quarter)	-5.23M	-8.07M	-10.39M	-7.73M	-7.24M	-10.14M	-6.70M					-6.24M				-5.87M				-7.08M
Revenue & cost
Revenue (Quarter)	0.06M
Non-operating items
Non Operating Investment Income (Quarter)				1.68M	0.68M	1.32M	1.12M	0.05M	-0.64M	0.29M	0.42M	-1.34M	0.51M	0.99M	0.00M					-1.12M
Interest & Investment Income (Quarter)	0.02M	0.03M	0.02M	0.06M	0.15M	0.30M	0.43M	0.40M	0.39M	0.38M	0.33M	0.28M	0.22M	0.15M	0.22M	0.17M	0.13M	0.09M	0.13M	0.15M
Other Non Operating Income (Quarter)	-0.13M	0.10M	1.49M	-1.08M	1.33M	2.28M	-0.39M	0.06M	-0.62M	0.50M	-0.46M	0.47M	0.11M	-0.10M	1.07M	-0.07M	-0.62M	0.07M	-0.22M	0.16M
Net income details
EBT (Quarter)	-5.20M	-8.05M	-10.57M	-7.67M	-7.09M	-9.84M	-6.38M					-5.96M				-5.70M				-6.93M
Profit After Tax (Quarter)	-5.34M	7.87M	-45.24M	7.07M	-5.09M	6.11M	-40.04M	-5.24M	5.56M	-4.42M	-35.71M	6.81M	-4.82M	9.33M	-5.85M	-5.78M	6.03M	-7.24M	-5.17M	-7.89M
Income from Continuing Operations (Quarter)	-5.20M	-8.05M	-10.57M	-7.67M	-7.09M	-9.84M	-6.38M					-5.96M				-5.70M				-6.93M
Consolidated Net Income (Quarter)	-5.20M	-8.05M	-10.57M	-7.67M	-7.09M	-9.84M	-6.38M					-5.96M				-5.70M				-6.93M
Income towards Parent Company (Quarter)	-5.20M	-8.05M	-10.57M	-7.73M	-7.24M	-10.14M	-6.38M	-5.76M	-4.70M	-5.71M		-6.24M	-5.66M	-10.37M		-5.70M	-6.08M	-7.40M		-6.93M
Net Income towards Common Stockholders (Quarter)	-5.20M	-8.05M	-10.57M	-7.73M	-7.24M	-10.14M	-6.38M	-5.76M	-4.70M	-5.71M		-6.24M	-5.66M	-10.37M		-5.70M	-6.08M	-7.40M		-6.93M
Additional items
EPS (Basic) (Quarter)	-0.13	-0.19	-0.24	-0.12	-0.12	-0.16	-0.10	-0.09	-0.07	-0.09		-0.09	-0.08	-0.15		-0.07	-0.07	-0.09		-0.06
EPS (Diluted) (Quarter)	-0.17	-0.27	-0.24	-0.18	-0.17	-0.23	-0.10	-0.09	-0.08	-0.09		-0.10	-0.09	-0.16		-0.08	-0.09	-0.10		-0.08
Shares Outstanding (Quarter)	40.06M	43.17M	43.22M	61.93M	61.93M	62.34M	62.51M	64.09M	64.11M	64.49M	64.46M	67.26M	68.75M	69.84M	71.57M	82.61M	82.65M	84.73M	86.99M	108.99M
Shares Outstanding (Diluted) (Quarter)	29.86M	29.86M	43.22M	43.22M	43.22M	43.22M	62.51M	62.51M	62.51M	62.51M	64.46M	64.46M	64.46M	64.46M	71.57M	71.57M	71.57M	71.57M	86.99M	86.99M
EBITDA (Quarter)	-5.20M	-8.07M	-10.39M	-7.73M	-7.24M	-10.14M	-6.70M					-6.24M				-5.87M				-7.08M
Interest Expenses (Quarter)			0.20M				0.11M

Research Tools

Datasets

Plans

Developers

Cardiol Therapeutics CRDL Income Statement (2020-2026)

Research Tools

Datasets

Plans

Developers

Cardiol Therapeutics CRDL Income Statement (2020-2026)

Create an account

Sign In

Reset Password